China Resources Double-Crane Pharmaceutical Co Ltd (600062) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.040x

Based on the latest financial reports, China Resources Double-Crane Pharmaceutical Co Ltd (600062) has a cash flow conversion efficiency ratio of 0.040x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥487.90 Million ≈ $71.40 Million USD) by net assets (CN¥12.16 Billion ≈ $1.78 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check China Resources Double-Crane Pharmaceuti (600062) strategic asset index to assess the company's strategic physical and investment asset allocation.

China Resources Double-Crane Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how China Resources Double-Crane Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. See 600062 total equity for net asset value and shareholders' equity analysis.

China Resources Double-Crane Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of China Resources Double-Crane Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sinocelltech Group Ltd SHG:688520	0.137x
West African Resources Ltd AU:WAF	0.055x
Ichor Holdings Ltd NASDAQ:ICHR	-0.004x
Buckle Inc NYSE:BKE	0.264x
Yankey Engineering Co Ltd TW:6691	0.058x
Anadolu Efes Biracilik ve Malt Sanayi AS IS:AEFES	0.083x
Veidekke ASA OL:VEI	0.397x
DHT Holdings Inc NYSE:DHT	0.064x

Annual Cash Flow Conversion Efficiency for China Resources Double-Crane Pharmaceutical Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of China Resources Double-Crane Pharmaceutical Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see market value of China Resources Double-Crane Pharmaceuti.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥11.11 Billion ≈ $1.63 Billion	CN¥1.83 Billion ≈ $267.07 Million	0.164x	+17.31%
2023-12-31	CN¥11.79 Billion ≈ $1.73 Billion	CN¥1.65 Billion ≈ $241.56 Million	0.140x	+11.98%
2022-12-31	CN¥10.73 Billion ≈ $1.57 Billion	CN¥1.34 Billion ≈ $196.33 Million	0.125x	-2.30%
2021-12-31	CN¥10.48 Billion ≈ $1.53 Billion	CN¥1.34 Billion ≈ $196.22 Million	0.128x	-11.76%
2020-12-31	CN¥9.38 Billion ≈ $1.37 Billion	CN¥1.36 Billion ≈ $199.03 Million	0.145x	-12.59%
2019-12-31	CN¥8.68 Billion ≈ $1.27 Billion	CN¥1.44 Billion ≈ $210.69 Million	0.166x	-10.67%
2018-12-31	CN¥7.91 Billion ≈ $1.16 Billion	CN¥1.47 Billion ≈ $214.97 Million	0.186x	+22.81%
2017-12-31	CN¥7.85 Billion ≈ $1.15 Billion	CN¥1.19 Billion ≈ $173.71 Million	0.151x	+38.03%
2016-12-31	CN¥7.04 Billion ≈ $1.03 Billion	CN¥771.25 Million ≈ $112.86 Million	0.110x	+0.52%
2015-12-31	CN¥6.43 Billion ≈ $941.48 Million	CN¥701.35 Million ≈ $102.63 Million	0.109x	-13.74%
2014-12-31	CN¥5.68 Billion ≈ $831.80 Million	CN¥718.38 Million ≈ $105.12 Million	0.126x	+23.46%
2013-12-31	CN¥5.34 Billion ≈ $780.86 Million	CN¥546.24 Million ≈ $79.93 Million	0.102x	+21.65%
2012-12-31	CN¥4.71 Billion ≈ $688.74 Million	CN¥396.05 Million ≈ $57.95 Million	0.084x	-28.55%
2011-12-31	CN¥4.34 Billion ≈ $635.56 Million	CN¥511.53 Million ≈ $74.85 Million	0.118x	-9.28%
2010-12-31	CN¥3.93 Billion ≈ $574.49 Million	CN¥509.67 Million ≈ $74.58 Million	0.130x	+34.17%
2009-12-31	CN¥3.53 Billion ≈ $517.25 Million	CN¥342.01 Million ≈ $50.05 Million	0.097x	-8.10%
2008-12-31	CN¥3.15 Billion ≈ $461.01 Million	CN¥331.71 Million ≈ $48.54 Million	0.105x	+5.74%
2007-12-31	CN¥2.36 Billion ≈ $346.03 Million	CN¥235.46 Million ≈ $34.45 Million	0.100x	-34.59%
2006-12-31	CN¥2.00 Billion ≈ $291.96 Million	CN¥303.71 Million ≈ $44.44 Million	0.152x	+111.19%
2005-12-31	CN¥1.94 Billion ≈ $283.78 Million	CN¥139.78 Million ≈ $20.45 Million	0.072x	-72.56%
2004-12-31	CN¥1.73 Billion ≈ $252.76 Million	CN¥453.72 Million ≈ $66.39 Million	0.263x	+202.75%
2003-12-31	CN¥1.72 Billion ≈ $251.20 Million	CN¥148.94 Million ≈ $21.79 Million	0.087x	-0.99%
2002-12-31	CN¥1.60 Billion ≈ $234.85 Million	CN¥140.63 Million ≈ $20.58 Million	0.088x	-7.41%
2001-12-31	CN¥1.49 Billion ≈ $218.03 Million	CN¥141.01 Million ≈ $20.63 Million	0.095x	-53.16%
2000-12-31	CN¥855.27 Million ≈ $125.15 Million	CN¥172.81 Million ≈ $25.29 Million	0.202x	+9.25%
1999-12-31	CN¥711.23 Million ≈ $104.08 Million	CN¥131.54 Million ≈ $19.25 Million	0.185x	+826.55%
1998-12-31	CN¥541.45 Million ≈ $79.23 Million	CN¥-13.78 Million ≈ $-2.02 Million	-0.025x	--

About China Resources Double-Crane Pharmaceutical Co Ltd

SHG:600062 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.56 Billion

CN¥17.50 Billion CNY

Market Cap Rank

#5534 Global

#1100 in China

Share Price

CN¥16.85

Change (1 day)

-1.23%

52-Week Range

CN¥16.81 - CN¥21.22

All Time High

CN¥33.06